ATE555095T1 - Verfahren zur herstellung von 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1, -dihydropyridin-2- carbonsäureamid und damit verwandten analoga - Google Patents

Verfahren zur herstellung von 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1, -dihydropyridin-2- carbonsäureamid und damit verwandten analoga

Info

Publication number
ATE555095T1
ATE555095T1 AT05810777T AT05810777T ATE555095T1 AT E555095 T1 ATE555095 T1 AT E555095T1 AT 05810777 T AT05810777 T AT 05810777T AT 05810777 T AT05810777 T AT 05810777T AT E555095 T1 ATE555095 T1 AT E555095T1
Authority
AT
Austria
Prior art keywords
formula
alkyl
compound
dihydropyridine
oxo
Prior art date
Application number
AT05810777T
Other languages
English (en)
Inventor
Tim Tam
Regis Leung-Toung
Yanqing Zhao
Wanren Li
Yingsheng Wang
Sandra Agostino
Birenkumar Shah
Original Assignee
Apotex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apotex Inc filed Critical Apotex Inc
Application granted granted Critical
Publication of ATE555095T1 publication Critical patent/ATE555095T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT05810777T 2004-11-19 2005-11-17 Verfahren zur herstellung von 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1, -dihydropyridin-2- carbonsäureamid und damit verwandten analoga ATE555095T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002488034A CA2488034C (en) 2004-11-19 2004-11-19 Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
PCT/CA2005/001746 WO2006053429A1 (en) 2004-11-19 2005-11-17 Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues

Publications (1)

Publication Number Publication Date
ATE555095T1 true ATE555095T1 (de) 2012-05-15

Family

ID=36406138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05810777T ATE555095T1 (de) 2004-11-19 2005-11-17 Verfahren zur herstellung von 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1, -dihydropyridin-2- carbonsäureamid und damit verwandten analoga

Country Status (6)

Country Link
US (1) US7893269B2 (de)
EP (1) EP1824823B1 (de)
CN (1) CN101094834B (de)
AT (1) ATE555095T1 (de)
CA (1) CA2488034C (de)
WO (1) WO2006053429A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009511568A (ja) * 2005-10-13 2009-03-19 ワラタ ファーマシューティカルズ, インコーポレイテッド イノシトール誘導体、ならびに異常なタンパク質の折りたたみまたは凝集、あるいはアミロイドの形成、沈着、蓄積または残存を特徴とする疾患の処置におけるその使用
PT2660239T (pt) 2008-07-25 2017-02-24 Shionogi & Co Compostos químicos como intermediários sintéticos
MX351942B (es) 2008-12-11 2017-11-03 Shionogi & Co Sintesis de inhibidores de integrasa de vih de carbamoil-piridona e intermediarios.
EP2376453B1 (de) 2008-12-11 2019-11-20 VIIV Healthcare Company Zwischenprodukte für carbamoylpyridone als hiv-integrase-inhibitoren
TWI518084B (zh) 2009-03-26 2016-01-21 鹽野義製藥股份有限公司 哌喃酮與吡啶酮衍生物之製造方法
TWI582097B (zh) 2010-03-23 2017-05-11 Viiv醫療保健公司 製備胺甲醯吡啶酮衍生物及中間體之方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78491B (de) 1982-03-24 1984-09-27 Nat Res Dev
CA1317298C (en) 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
GB9217099D0 (en) 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
DE59611243D1 (de) 1995-09-29 2005-08-11 Novartis Ag Hydroxypyridinone
GB9711093D0 (en) * 1997-05-29 1997-07-23 British Tech Group Novel orally active iron (III) chelators
US6465229B2 (en) 1998-12-02 2002-10-15 E. I. Du Pont De Nemours And Company Plant caffeoyl-coa o-methyltransferase
US6426418B1 (en) * 2001-11-02 2002-07-30 Apotex, Inc. Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
CA2379370A1 (en) 2002-03-28 2003-09-28 Apotex Inc. Carboxylic acid derivatives of 3-hydroxy-4-oxo-1,4-dihydropyridine as iron chelators
NZ529657A (en) 2003-11-20 2004-07-30 Apotex Inc Iron chelating cycloalkyl derivatives of 3-hydroxy-4-pyridinones

Also Published As

Publication number Publication date
CN101094834A (zh) 2007-12-26
EP1824823B1 (de) 2012-04-25
WO2006053429A1 (en) 2006-05-26
CA2488034A1 (en) 2006-05-19
CA2488034C (en) 2009-10-06
US20080096886A1 (en) 2008-04-24
US7893269B2 (en) 2011-02-22
EP1824823A4 (de) 2009-09-23
CN101094834B (zh) 2012-03-07
EP1824823A1 (de) 2007-08-29

Similar Documents

Publication Publication Date Title
DE602005023459D1 (de) Verfahren zur herstellung und reinigung von 2-hydrocarbyl-3,3-bis(4-hydroxyaryl-phthalimidin-monomeren
EP1541561A4 (de) Pyrazolderivate und verfahren zu deren herstellung
DE60311599D1 (de) Verfahren zur herstellung von duloxetin und deren verwendeten zwischenprodukten
IS5883A (is) Aðferð til framleiðslu á hreinu sítalóprami
WO2008082502A3 (en) Process for preparing 2-amino-5-cyanobenzoic acid derivatives
ATE538085T1 (de) Verfahren zur herstellung von 2-amino-5- cyanobenzoesäurederivaten
WO2009006061A3 (en) Process for preparing 2-amino-5-cyanobenzoic acid derivatives
NZ596025A (en) [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto
ATE413377T1 (de) Verfahren zur kontinuierlichen quaternisierung tertiärer amine mit einem alkylhalogenid
KR20210066768A (ko) 광학 활성 다이아민 유도체 및 티아졸 유도체의 생산을 위한 새로운 합성경로
ATE555095T1 (de) Verfahren zur herstellung von 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1, -dihydropyridin-2- carbonsäureamid und damit verwandten analoga
ATE513801T1 (de) Verfahren zur synthese von propargylatierten aminoindanderivativen
ATE455088T1 (de) Asymmetrische reduktive aminierung von ketosäurederivaten zur herstellung von aminosäurederivaten
EP2307355B1 (de) Neue Synthese von substituierten 4-Amino-pyrimidinen
SK24194A3 (en) Method of preparation of aqueous solution of nicotinealdehyde
ATE443045T1 (de) Verfahren zur herstellung von 1-halogen-2,7- naphthyridinylderivaten
ATE423096T1 (de) Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten
EP1661894A4 (de) Verfahren zur herstellung von 4-aminotetrahydropyranen und deren salzen mit säuren, zwischenprodukte für das verfahren und verfahren zur herstellung davon
DE60230366D1 (de) Verfahren zur Herstellung eines optisch aktiven Amids ausgehend von einem alpha, beta-ungesättigtem Amid Derivat in Anwesenheit eines optisch aktiven Übergangsmetallkomplexes, der eine Phosphin-Phosphoran Verbindung und Rhodium enthält
JP4478827B2 (ja) アミンボランを用いるアミンの製造方法
EA200700897A1 (ru) Способ получения хирально чистой кристаллической модификации натеглинида
KR100982884B1 (ko) 1,2-비스(3,5-디옥소피페라지닐)프로판의 제조방법
Ghasemi et al. Sulfuric acid {[3-(3-silicapropyl) sulfanyl] propyl} ester as a recyclable solid acid catalyst for the synthesis of α-amino nitriles
JPS63503384A (ja) 1‐置換(s)‐および(r)‐2‐アミノメチルピロリジン類の有効な立体保存的合成およびその中間体
JP4769464B2 (ja) アルコール化合物の製造方法